Stock Symbol:

ARIA

Company Name:

ARIAD Pharmaceuticals, Inc.

Company Description:

Develops orally-administered drugs which block intracellular signal transduction pathways, which are critical to major diseases such as osteoporosis, allergy/asthma and immune-related disorders; Develops systems to regulate gene therapy.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

M-J-S-D

Stock Exchange:

NASDAQ

Predicted Split Price:

$19.00

Predicted Split Ratio:

5 for 4

5 Day Performance After Split:

2.2%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.